21.05.07 22:15 (BUSINESS WIRE) IDM Pharma to Present at 6th Annual JMP Securities Research Conference 15.05.07 14:00 (BUSINESS WIRE) IDM Pharma Reports First Quarter 2007 Financial Results 09.05.07 19:32 (BUSINESS WIRE) FDA Advisory Committee Reviews Data on IDM Pharma's Junovan(TM) (mifamurtide) for Treatment of Osteosarcoma 07.05.07 14:00 (BUSINESS WIRE) IDM Pharma to Hold Post Advisory Committee Conference Call 04.05.07 14:00 (BUSINESS WIRE) IDM Pharma Appoints Robert De Vaere as Senior Vice President and CFO 19.04.07 14:00 (BUSINESS WIRE) IDM Pharma Appoints Edward E. Penhoet, Ph.D to Board of Directors 03.04.07 16:35 (BUSINESS WIRE) IDM Pharma Inc. Announces Oncologic Drugs Advisory Committee Meeting for Junovan(TM) (Mifamurtide) Will Take Place on May 9, 2007 02.04.07 14:00 (BUSINESS WIRE) IDM Pharma Reports 2006 Financial Results 28.02.07 14:00 (BUSINESS WIRE) IDM Pharma Announces the Completion of Enrollment in Two Phase II Trials of Uvidem(R) in Melanoma 21.02.07 14:00 (BUSINESS WIRE) IDM Pharma Raises $12.8 Million in Private Placem |